Fig. 2
From: Targeting and limiting surgery for patients with node-positive breast cancer
ACOSOG Z1071 Trial [7]. The ACOSOG Z1071 trial was designed to test the reliability of sentinel lymph node dissection to restage the axillary lymph nodes after neoadjuvant chemotherapy in patients presenting with clinically positive lymph nodes